Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…
Demand for hair loss treatments is declining in 2023 following strong growth in recent years as COVID-19 and subsequent inflationary pressure boosted prevalence of hair loss due to stress and anxiety. Although the latter remains an overbearing issue…
Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…
Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…
Sales of dermatologicals strongly rely on consumers visiting pharmacies (the dominant distribution channel) as Belgians rarely go first to these stores specifically to purchase such products. Instead these are generally secondary purchases alongside…
With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…
Dermatologicals continues to achieve strong growth in 2023 driven by health and wellness trends and premiumisation in some product categories. Rising unit prices in response to inflation, which has impacted the entire consumer health category, has…
Dermatologicals is projected to continue to see positive, if slow, retail value (constant 2023 prices) growth in 2023. However, after posting robust retail volume gains in 2021 and 2022, most categories are projected to see declines in retail volume…
Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…
In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…
Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…
Rising consumer demand for medicated skin care products continues to boost sales of dermatologicals in 2023. The desire for well-groomed and healthy skin is extending from beauty and personal care into dermatological products, although products in…
Dermatologicals is expected to register an increase in current value sales in 2023, partly as a result of the energy crisis stemming from the war in Ukraine, which is pushing up retail prices.
Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…
Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…
Value growth for dermatologicals continues to slow in 2023 as local consumers prioritise the treatment of other health concerns. According to a study led by the French Society of Dermatology (SFD), one in three French citizen suffers from a skin…
Dermatologicals has seen demand weaken in the post-pandemic period. While certain COVID-19 related habits, such as the use of hand sanitisers, remain relevant and people in Greece continue to use them much more than they did in the past, this is a…
Dermatologicals is seeing solid current value growth in 2023, driven in part by higher retail prices. The category is benefiting from a return to normal daily lifestyles following the COVID-19 pandemic. Consumers’ skin is being more exposed to…
The incidence of head lice is rising back to normal levels in 2023 as children circulate freely in schools and at social gatherings, and kids play close together. With retail volume sales back to pre-pandemic levels in 2022, demand for…
Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…
Dermatologicals has performed impressively in 2023, with all categories set to record stronger volume growth rates than in 2022. Demand for some product types has picked up as the increased levels of social contact brought about by the easing of the…
Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively…
In general, dermatologicals was largely unaffected by the Coronavirus (COVID-19) pandemic. Most categories of dermatologicals continued to see retail volume growth in 2020, many of them at a similar rate to 2019. There are a number of underlying…
Hair loss treatments in the United Arab Emirates has been experiencing increased fragmentation, due to the emergence of numerous new entrants, with the value share of the smallest players, included under “others” set to rise above 50% for the first…
2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…
Despite another positive performance by dermatologicals in 2023, the category is recording significantly slower growth rates compared to 2022. The dynamic growth in 2022 was due to the fact that after the lifting of restrictions in Vietnam, local…
Affordability is a key factor within dermatologicals, with some products on the landscape being very expensive for the average consumer. As such, people need to find products within their budget, allowing them to address their specific skin issues.…
Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…
Healthy growth in dermatologicals is stemming from launches of value-added products. There was a pause on most new product development activity during the COVID-19 crisis, but with the end of the pandemic, products that had been held back have been…
Most types of dermatologicals saw an upward sales trend in retail volume terms in 2023, although the rate of expansion was lower than that seen in many other consumer health categories. Despite the increasing incidence of diagnosed skin diseases…
Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…
International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…
In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…
After recording strong growth in 2022, sales of many dermatologicals in 2023 are weakening. Declining disposable incomes due to elevated inflation and higher interest rates are eroding the interest of Spaniards in spending on perceived non-essential…
Dermatologicals is projected to continue to post strong retail current value growth in 2023. Increasing retail value sales have, on the one hand, been influenced by rising unit prices, amid a highly inflationary climate. In addition, hair loss…
Dermatologicals is set to see a strong performance in 2023, with all the major categories seeing mid to high single-digit growth in retail current value terms. Antifungals (topical antifungals and vaginal antifungals) is one of the largest categories…
In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer…
Dermatologicals is expected to register moderate constant value growth in 2023. Geopolitical tensions in the region have led to a significant increase in the number of immigrants from Ukraine, Russia and Belarus, and this is expected to contribute to…
Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…
Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…
Although dermatologicals continues to enjoy steady growth in 2023, current value sales have slowed down compared to the double-digit rates seen at the height of the COVID-19 pandemic. Whilst spending more time at home, Latvian consumers became…
The dermatologicals landscape is experiencing a downward momentum in some categories, which have found themselves losing share and importance following the outbreak of COVID-19. Topical Germicidals/Antiseptics is one of the categories which is set to…
In line with the overall performance of skin care products in beauty and personal care in North Macedonia, dermatologicals is one of the fastest growing consumer health category thanks to strong and continued consumer demand. The product and brand…
Hair loss treatments is expected to continue to see strong retail volume and current value growth over 2023. Indeed, hair loss treatments is projected to record the fastest retail volume growth at the end of the review period. Mild-to-severe hair…
Dermatologicals experienced a modest decline in overall constant value terms in 2023, although performance varied considerably according to subcategory. One notable development was the buoyant demand for antiparasitics/lice treatments, continuing the…
Dermatologicals in Tunisia is experiencing robust growth in current value terms in 2023 with this being driven by several factors that are contributing to the category’s success. One of the key drivers is the rising urbanisation of the population in…
Hair weakens and becomes vulnerable to shedding due to reasons like seasonality (seasonal transitions), stress, hormonal changes and thermal applications. For this reason, hair loss treatments tends to see increases in demand in spring and autumn,…
Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…
The sedentary lifestyles that are prevalent in Bulgaria significantly impact the market for dermatological products. A lack of physical activity often goes hand in hand with prolonged periods of sitting indoors, which can lead to reduced exposure to…
All dermatologicals categories in Hungary are expected to post negative results in volume terms in 2023, in most cases for the second year in a row. Although a number of different factors have depressed demand in individual categories, the overall…